Cis-5-Dodecenoic Acid NEW
Price | $37 | $59 |
Package | 10mg | 25mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-08 |
Product Details
Product Name: Cis-5-Dodecenoic Acid | CAS No.: 2430-94-6 |
Purity: 99.37% | Supply Ability: 10g |
Release date: 2024/11/08 |
Product Introduction
Bioactivity
名稱 | Cis-5-Dodecenoic Acid |
描述 | Cis-5-Dodecenoic Acid is a monounsaturated fatty acid that has a C12 chain as a backbone and a cis double bond at the C5 position. |
存儲(chǔ)條件 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 50 mg/mL (252.14 mM) |
關(guān)鍵字 | Cis 5 Dodecenoic Acid | Cis5Dodecenoic Acid | inhibit | Inhibitor | COX | Endogenous Metabolite | Cis-5-Dodecenoic Acid | Cyclooxygenase |
相關(guān)庫 | 植物來源化合物庫 | 天然產(chǎn)物庫 | 高通量篩選天然產(chǎn)物庫 | Ro5類藥天然產(chǎn)物庫 | 人內(nèi)源代謝化合物庫 | 人內(nèi)源代謝化合物庫 Plus | 人代謝物化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$20.00/1kg |
VIP5Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-09-28 | |
$42.00/100mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
$219.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-07 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY